AI Tool Identifies Better Antibody Therapies
Georgia Tech researchers created AF2Complex, a deep-learning tool that predicts antibody interactions with proteins, ...
Healthline9d
Medicare Coverage for COVID-19 Tests
Medicare Part B covers molecular, antigen, and antibody coronavirus testing from Medicare-approved labs. Medicare does not cover over-the-counter home test kits. Various tests can detect COVID-19 ...
mayo5h
Project 1: Targeting Resistance to T Cell-Directed Therapy in Multiple Myeloma
Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...
News Medical10d
Elevated antibody responses to Epstein-Barr virus linked to increased risk of multiple sclerosis
Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with ...
Benzinga.com2d
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Interim results show positive antibody responses were effectively induced against the target antigen at week 6 after two ...
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...
Monthly Prescribing Reference8d
GPRC5D-Targeting Bispecific Antibody Gets Orphan Drug Status for Multiple Myeloma
The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.